Search
06/09/2021
Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial
Abolbaghaei, A, Langlois, MA, Murphy, HR, Feig, DS, Burger, D, Corcoy R., CONCEPTT Collaborative Grp. Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial. Biomarker Research. 2021; 9(1)DOI:10.1186/s40364-021-00322-8. PMID:34488911. IF:8.633(Q1/2D).
02/09/2021
Lung function changes in patients with chronic obstructive pulmonary disease (COPD) and asthma exposed to secondhand smoke in outdoor areas
Keogan, S, Alonso, T, Sunday, S, Tigova, O, Fernandez, E, Lopez, MJ, Gallus, S, Semple, S, Tzortzi, A, Boffi, R, Gorini, G, Lopez-Nicolas, A, Radu-Loghin, C, Soriano, JB, Clancy, L, TackSHS Project Investigators. Lung function changes in patients with chronic obstructive pulmonary disease (COPD) and asthma exposed to secondhand smoke in outdoor areas. JOURNAL OF ASTHMA. 2021; 58(9)DOI:10.1080/02770903.2020.1766062. PMID:32441557. IF:2.000(Q4/9D).
02/09/2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Gerstein, HC, Sattar, N, Rosenstock, J, Ramasundarahettige, C, Pratley, R, Lopes, RD, Lam, CSP, Khurmi, NS, Heenan, L, Del Prato, S, Dyal, L, Branch, K, Sionis A., AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE. 2021; 385(10)DOI:10.1056/NEJMoa2108269. PMID:34215025. IF:176.082(Q1/1D).
02/09/2021
Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa
Roman, MTA, Benitez, O, Canaro, MI, Fernandez, MFL, Jaime, FLJ, Arranz, JM, Nunez, R, Lopez, MR, Aisa, CS, Jimenez-Yuste, V. Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021; 21(9)DOI:10.1080/14712598.2021.1932811. PMID:34225551. IF:5.589(Q1/3D).
02/09/2021
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R, Diaz-Cuervo, H, Aragao, F, Munoz, J, Galindo, P, Merino, M, de la Fuente, B, Sepulveda, MA, Domingo, P, Garcia, J, Castano, M, Ribera, E, Geijo, P, Romero, A, Peraire, J, Deig, E, Roca, B, Martinez, E, Estrada, V, Montero, M, Berenguer, J, Espinosa, N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3)DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1.676(Q4/9D).
01/09/2021
TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy 18th June 2019, Amsterdam, The Netherlands
Guglieri, M, Diaz-Manera, J, Straub, V. TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy 18th June 2019, Amsterdam, The Netherlands. NEUROMUSCULAR DISORDERS. 2021; 31(9)DOI:10.1016/j.nmd.2021.06.011. PMID:34426054. IF:3.538(Q2/5D).